ALIGOS THERAPEUTICS INC COM NEW - Stock (ALGS)

CUSIP: 01626L105

Q3 2025 13F Holders as of 30 Sep 2025

Share change
+90
SEC-reported price per share
$9.80
Number of holders
1
Value change
+$882
Number of buys
1

Security key

01626L105

Report period

Q3 2025

Institutions

1

Top holders

0

Ownership snapshot

Top reported holders of ALGS - ALIGOS THERAPEUTICS INC COM NEW - Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
Woodline Partners LP
Comparable rows
4/15
Latest evidence
30 Jun 2025
13F 13D/G 3/4/5 Lead comparable stake: 10% 11 rows are not safely comparable across share classes. 13D/G row: Alyeska Investment Group, L.P. Showing 1-6 of 15 holder rows.

Quick read

Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 10%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership Top 4
Alyeska Investment Group, L.P. 10%
ARMISTICE CAPITAL, LLC 5%
Adage Capital Management, L.P. 3.9%
EcoR1 Capital, LLC 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alyeska Investment Group, L.P.
13F 13D/G
Company
10%
Reported 13D/G · 31 Mar 2025
$2,970,520
412,000 shares
— 30 Jun 2025
ARMISTICE CAPITAL, LLC
13D/G
5%
Reported 13D/G · 31 Dec 2024
$998,721
188,438 shares
$0 31 Dec 2024
Adage Capital Management, L.P.
13D/G
3.9%
Reported 13D/G · 30 Jun 2025
$1,514,100
210,000 shares
-$829,150 30 Jun 2025
EcoR1 Capital, LLC
13D/G
3.9%
Reported 13D/G · 31 Mar 2025
$1,116,360
210,634 shares
$0 31 Mar 2025
ROCHE HOLDING LTD
3/4/5
10%+ Owner
—
denominator unverified
—
11,025,941 shares
— 25 Oct 2023
Woodline Partners LP
13F
Company
13F
—
denominator unverified
$3,736,943
518,300 shares
— 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q3 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of ALGS - ALIGOS THERAPEUTICS INC COM NEW - Stock as of Q3 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .